Covid-19 roundup: Bris­tol My­ers sus­pends clin­i­cal tri­als, grounds field team; Vir ush­ers an­ti­body can­di­dates to hu­man test­ing

The glob­al na­ture of the Covid-19 pan­dem­ic is man­i­fest­ing more pro­found­ly every day. With Spain’s death toll now sur­pass­ing Chi­na’s and In­dia on full lock­down, the num­ber of con­firmed cas­es around the world has ex­ceed­ed 436,000 while re­cov­er­ies edged close to 112,000.

While the out­break de­rails R&D at an­oth­er phar­ma gi­ant, sev­er­al drug­mak­ers have some en­cour­ag­ing up­dates on both ex­per­i­men­tal and re­pur­posed mol­e­cules. Phil­an­thropic cam­paigns in an­tic­i­pa­tion of the eco­nom­ic fall­out con­tin­ue. An Aus­tralian biotech is tak­ing ex­treme mea­sures to hun­ker down. There’s al­so an al­ter­na­tive epi­demi­ol­o­gy mod­el emerg­ing out of the UK, stir­ring up more dis­cus­sion re­gard­ing the true ex­tent of the in­fec­tions in the coun­try.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER